Background: Proposed International Classification of Diseases, 11th edition (ICD-11), criteria for substance use disorder (SUD) radically simplify the algorithm used to diagnose substance dependence. Major differences in case identification across DSM and ICD impact determinations of treatment need and conceptualizations of substance dependence. This study compared the draft algorithm for ICD-11 SUD against DSM-IV, DSM-5, and ICD-10, for alcohol and cannabis.
Specifically, DSM-IV defined mutually exclusive diagnoses of substance abuse (1 of 4 symptoms needed for diagnosis) and dependence (3 of 7 symptoms) using 2 distinct sets of symptoms. In DSM-5, recurrent legal problems were dropped as a criterion, and in accord with ICD-10 dependence, criteria for "craving" and cannabis withdrawal were added. A major change in DSM-5 is the use of a single set of 11 SUD criteria to determine a diagnosis of mild (2 to 3 symptoms), moderate (4 to 5 symptoms), or severe (≥ 6 symptoms) SUD.
Similar to DSM-IV, ICD-10 defines 2 mutually exclusive SUD diagnoses. However, in contrast to DSM-IV abuse (indicated by substance-related impairment in major role obligations, interpersonal problems due to use, substancerelated legal problems, or hazardous use), ICD-10's harmful use diagnosis is determined by symptoms of psychological or physical harm caused by substance use. ICD-10 dependence (3 of 6 symptoms needed for diagnosis) is similar to DSM-IV dependence, but includes Craving, and combines DSM-IV dependence criteria representing "using more or longer than intended" (Larger/Longer) and "repeated attempts to quit or cut down" (Quit/Cut Down) into 1 criterion. In addition, DSM-IV dependence criteria representing a lot of time spent using (Much Time) and giving up important activities to use (Reduce Activities) are combined into 1 ICD-10 criterion.
A draft of the ICD-11 SUD algorithm proposes to retain mutually exclusive SUD diagnoses of harmful use (as defined in ICD-10) and dependence (Tyburski et al., 2014) . ICD-11 expands the ICD-10 harmful use diagnosis to include "family harmed by substance use." The main and substantial simplification of proposed ICD-11 SUD involves reducing the 6 ICD-10 dependence criteria to only 3 criteria: Physical Dependence (Tolerance or Withdrawal), Priority of Use (Much Time or Reduce Activities, or Psychological/Physical harm), and Impaired Control (Quit/Cut or Larger/Longer, or Craving) (Poznyak, 2016; Tyburski et al., 2014; World Health Organization, 2014) . Symptoms from at least 2 of the 3 proposed ICD-11 dependence criteria need to be present for a diagnosis. Limited research has examined how this substantial simplification of the ICD-10 dependence algorithm will affect SUD prevalence and case coverage in a clinical sample of adolescents where ICD coding may need to be applied for medical record and reimbursement purposes.
Prevalence and Diagnostic Concordance Across Classification Systems
DSM-IV and DSM-5: SUD versus No SUD. Analyses leading to DSM-5 indicated high concordance between any DSM-IV and DSM-5 SUD using a threshold of ≥ 2 of 11 criteria (Hasin et al., 2013b) . However, a review of AUD prevalence across 12 clinical and general population studies found an increase in prevalence from DSM-IV to DSM-5 in 7 studies, no difference in 2 studies, and a decrease in 3 studies (Bartoli et al., 2015) . In a pediatric sample, SUD prevalence was higher in DSM-5, compared to DSM-IV for both alcohol (4.6% vs. 3.8%) and cannabis (10.7% vs. 8.2%) (Kelly et al., 2014) . Despite the difference in prevalence across DSM-IV and DSM-5, their concordance for AUD or CUD was high in a pediatric sample (kappa for AUD = 0.81, CUD = 0.84) (Kelly et al., 2014) .
DSM-IV, DSM-5, ICD-10, and ICD-11: SUD versus No SUD. Prevalence of AUD is generally greater using DSM-IV compared to ICD-10 (Hasin et al., 1996; Pollock et al., 2000) , primarily due to cases that qualify for DSM-IV alcohol abuse, but have no ICD-10 diagnosis (Hasin et al., 1996) . A comparison of DSM-IV, DSM-5, and ICD-10 found that DSM-5 produced the highest AUD prevalence (11.0%), followed by DSM-IV (8.7%) and ICD-10 (4.9%) in a Swedish general population sample (Lundin et al., 2015) . The increase in AUD prevalence from DSM-IV to DSM-5 was due to DSM-IV subthreshold cases of dependence that met criteria for DSM-5 mild AUD (i.e., met 2 AUD symptoms) (Lundin et al., 2015) . In contrast, results from an Australian general population sample indicated that prevalence of any AUD among drinkers was highest in ICD-10 (36.1%), followed by DSM-IV (35.3%), ICD-11 (33.3%), and DSM-5 (31.0%) (Lago et al., 2016) . A similar rank ordering of prevalence was found for CUD in the Australian general population sample (Lago et al., 2016) . One study which examined concordance found high agreement between DSM-5 and DSM-IV AUD (kappa = 0.84), but only moderate agreement between DSM-5 and ICD-10 (kappa = 0.62) (Lundin et al., 2015) .
DSM-IV and ICD-10 Dependence, and DSM-5 Moderate to Severe Use Disorder. When examining only the prevalence of the more severe DSM-IV and ICD-10 dependence diagnoses and DSM-5 moderate to severe use disorder (DSM-5 M/S), the rank ordering in the Australian sample (i.e., DSM-5 M/S > DSM-IV and ICD-10 dependence) was similar to Swedish (Lundin et al., 2015) and U.S. samples (Proctor et al., 2016) . Further, the Australian study found that prevalence of DSM-5 M/S was higher than ICD-11 dependence for alcohol and cannabis (Lago et al., 2016) . For both substances, DSM-IV, ICD-10, and ICD-11 dependence showed high agreement (kappas = 0.90 to 0.99), but only moderate agreement with DSM-5 M/S (kappas = 0.61 to 0.70). DSM-5 M/S appeared to identify a different group of alcohol and cannabis users, compared to DSM-IV, ICD-10, and ICD-11 dependence in the Australian study (Lago et al., 2016) . The extent to which DSM-5 M/S and ICD-11 dependence criteria identify the same cases has not been examined in an adolescent treatment sample, despite the implications of possible inconsistencies in diagnostic coverage across systems for determining treatment need, at a point in the lifespan when substancerelated problems first begin to emerge.
Current Study Aims
This study compared the proposed algorithm for ICD-11 SUDs against DSM-IV, DSM-5, and ICD-10, for alcohol and cannabis, as these 2 substances are commonly used among adolescents in treatment (Substance Abuse and Mental Health Services Administration, 2016). Prevalence of diagnoses and symptoms, and diagnostic concordance across the classification systems were examined. Due to the substantial changes proposed for ICD-11 dependence, and that ICD-11 and DSM-5 may be used concurrently, we examined prevalence and concordance of proposed ICD-11 dependence and DSM-5 M/S (DSM-5 M/S is generally considered to be comparable to DSM-IV dependence; Compton et al., 2013; Goldstein et al., 2015) . We also identified sources of diagnostic switching (i.e., "loss" or "gain" of diagnostic status) for DSM-5 M/S and proposed ICD-11 dependence to determine sources of diagnostic disagreement.
Based on prior work (Lago et al., 2016) , we hypothesized that prevalence of DSM-5 M/S would be higher than ICD-11 dependence, for both alcohol and cannabis. We also predicted that concordance between ICD-11 dependence and DSM-5 M/S would only be moderate, because DSM-5 M/S includes commonly endorsed criteria (e.g., hazardous use) that are not used to diagnose ICD-11 dependence. Finally, we explored the extent to which ICD-11 and DSM-5 diagnoses differed on frequency of alcohol and cannabis use, and number of symptoms reported, as indicators of substance use severity.
MATERIALS AND METHODS

Participants
Adolescents (ages 14 to 18) admitted to community-based intensive outpatient treatment (IOP) for addictions were approached to participate in research interviews assessing youth alcohol and drug use, which are detailed elsewhere (Chung et al., 2015; King et al., 2009) . Among youth who expressed initial interest in study participation, 339 (30.4% female; mean age = 16.8, SD = 1.1; 85.3% Caucasian, 8.0% African American, 6.8% other race/ethnicity) completed a research assessment, typically within 2 weeks of starting treatment. Adolescents were receiving treatment primarily for cannabis and/or alcohol use. Sample demographic and substance use characteristics are generally similar to those of youth admitted to publicly funded substance use treatment (Substance Abuse and Mental Health Services Administration, 2011).
Procedure
Youth admitted to a community-based IOP substance use treatment program, which operated 6 regional sites, were approached to participate. All sites were part of the same overall treatment program, such that treatment format and content (consisting of cognitive behavioral substance use treatment and 12-step facilitation) were similar across all sites. Informed consent or assent (from minor participants, with parent consent for the minor's participation) was obtained prior to study participation. The research assessment was completed at research offices by trained interviewers. Youth were compensated for study participation. The University of Pittsburgh Institutional Review Board approved the protocol.
Measures
A Structured Clinical Interview for DSM-IV SUDs (SCID), adapted for use with adolescents, for example, by querying effects of substance use on academic performance (First et al., 2002; Martin et al., 2000) , was administered by research interviewers to determine past-year alcohol and cannabis diagnoses and symptom counts. The adapted SCID has been used to assess DSM-and ICD-based SUDs in a different sample of adolescents . The adapted SCID queries onset and offset of symptoms to the nearest month, which permits determination of clustering or co-occurrence of symptoms within a 12-month time frame. To be rated as present, a symptom needs to occur repeatedly and be associated with impairment in functioning. The adapted SCID assessed craving , but did not include the proposed ICD-11 symptom "family harmed by substance use." The adapted SCID had moderate to high interrater reliability for symptom ratings and reports of symptom onset and offset, and demonstrated good concurrent validity (Chung et al., 2004a; Martin et al., 2000) .
Frequency of alcohol and cannabis use (past 6 months) was reported on a 0 to 8 scale: 0 = never used, 1 = no use in the past 6 months, 2 = less than monthly, 3 = once per month, 4 = 2 to 3 times per month, 5 = once per week, 6 = 2 to 3 times per week, 7 = 4 to 6 times per week, 8 = daily.
Data Analysis
Diagnostic concordance was determined by kappa (Landis and Koch, 1977) . Comparisons of prevalence rates according to different diagnostic systems were conducted using McNemar tests of correlated proportions. Specifically, as concordance between DSM-IV dependence and DSM-5 SUD was maximized for alcohol when using ≥ 4 DSM-5 SUD criteria (Compton et al., 2013; Goldstein et al., 2015) , McNemar tests of correlated proportions were used to compare DSM-IV, ICD-10, and ICD-11 dependence against DSM-5 M/S use disorder (≥ 4 criteria). Exploratory comparisons of diagnostic groupings on frequency of substance use and symptom count were conducted using analysis of covariance, controlling for age and gender.
RESULTS
Diagnostic Prevalence and Concordance
SUD versus No SUD. Prevalence of past-year diagnosis of any AUD (Table 1) was highest in DSM-IV (43.7%), followed by DSM-5 (37.7%), ICD-11 (15.9%), and ICD-10 (8.3%). For past-year diagnosis of any CUD, a similar rank ordering was obtained: DSM-IV (89.4%), followed by DSM-5 (82.8%), ICD-11 (61.4%), and ICD-10 (43.1%). Compared to DSM-IV and DSM-5, prevalence of any proposed ICD-11 AUD or CUD (i.e., harmful use, dependence) was lower (McNemar tests of correlated proportions, ps < 0.01).
Diagnostic concordance for any past-year AUD (Table 2 ) was highest for DSM-IV and DSM-5 (kappa = 0.83), generally moderate for proposed ICD-11 with DSM-5 and ICD-10 (kappas = 0.48 to 0.64), and lowest for ICD-10 with DSM-IV and DSM-5 (kappas = 0.19 and 0.26). For any CUD, concordance between DSM-IV, DSM-5, and proposed ICD-11 was moderate (ICD-11 and DSM-5, kappa = 0.49) to substantial (DSM-IV and ICD-11, kappa = 0.76), but poor between ICD-10, DSM-IV, and DSM-5 (kappas = 0.15 to 0.27).
DSM-IV, ICD-10, ICD-11 Dependence and DSM-5 M/S. Given the substantial simplification proposed for ICD-11 dependence, we examined the prevalence of ICD-11 dependence relative to the other classification systems. For both alcohol and cannabis, prevalence was highest for ICD-11 dependence, followed by DSM-5 M/S, ICD-10, and DSM-IV (Table 1) . Prevalence of ICD-11 dependence for alcohol and cannabis was significantly higher compared to DSM-IV, DSM-5, and ICD-10 (McNemar tests of correlated proportions, ps < 0.01).
Concordance between DSM-IV, ICD-10, proposed ICD-11 dependence, and DSM-5 M/S for both alcohol and cannabis was generally moderate (Table 3 , alcohol: 0.50 to 0.73; cannabis: 0.56 to 0.78). Agreement between proposed ICD-11 dependence and DSM-5 M/S was relatively high (alcohol: 0.73, cannabis: 0.78), whereas agreement between ICD-10 and proposed ICD-11 dependence was moderate (alcohol: 0.55, cannabis: 0.65). Concordance was lowest for DSM-IV and proposed ICD-11 dependence diagnoses, for alcohol and cannabis (kappas: 0.50 and 0.56).
Symptom Prevalence
Among DSM-IV and DSM-5 SUD criteria, Interpersonal Problems and Tolerance were frequently endorsed for both alcohol and cannabis (Table 4) . For cannabis, Much Time also was endorsed by a majority (63.7%), whereas this symptom was endorsed less often for alcohol (9.7%). Withdrawal was reported more often due to cannabis (31.3%) than alcohol (1.2%) use.
Of the 3 ICD-11 dependence criteria, Physical Dependence and Priority of Substance Use were met most often for both alcohol and cannabis. Physical Dependence was typically present due to Tolerance, rather than Withdrawal (which included use of a substance to avoid withdrawal), for both For alcohol, 17 cases met criteria for proposed ICD-11 dependence, but did not have a DSM-5 M/S diagnosis (Table 5) . These 17 cases all reported Tolerance, which was followed in prevalence by Quit/Cut Down (41.2%) and Much Time (35.3%). Only 5 cases had a DSM-5 M/S alcohol diagnosis, but did not have proposed ICD-11 dependence. The 5 cases all endorsed Role Impairment, Hazardous Use, and Interpersonal Problems, with Tolerance reported by 80% of the cases. In terms of symptom count (12 possible: 11 DSM-IV Abuse and Dependence criteria, and Craving), the 17 cases with proposed ICD-11 alcohol dependence, but no DSM-5 M/S diagnosis, reported 2.8 criteria (SD = 0.4), on average. By comparison, the 5 cases with DSM-5 M/S AUD but no proposed ICD-11 dependence reported 4 symptoms (SD = 0.0). Although the type of symptoms reported by these 2 types of discordant cases differed, total alcohol symptom count and frequency of alcohol use were not significantly different for the 2 discordant groups.
For cannabis, 27 cases with proposed ICD-11 dependence did not have a DSM-5 M/S diagnosis (Table 5) . Almost all of these cases reported Tolerance (92.6%) and Much Time (81.5%). The 9 cases with a DSM-5 M/S cannabis diagnosis, but no proposed ICD-11 dependence, all reported Role Impairment and Interpersonal Problems, followed in prevalence by Hazardous Use (77.8%). When comparing these groups on cannabis symptom count, the 27 cases with proposed ICD-11 dependence, but no DSM-5 M/S diagnosis, reported an average of 2.9 symptoms (SD = 0.4). The 9 cases with DSM-5 M/S disorder but no proposed ICD-11 dependence diagnosis reported an average of 4.1 (SD = 0.6) symptoms. Similar to results for alcohol, type of cannabis symptoms reported by the 2 types of discordant cases differed, but cannabis symptom count and frequency of use did not significantly differ.
DISCUSSION
In this adolescent treatment sample, the proposed ICD-11 SUD algorithm diagnosed significantly fewer cases of any past-year AUD and CUD compared to DSM-IV and DSM-5, due to low prevalence of "harmful use" diagnosis. Concordance for any past-year ICD-11 and DSM-5 AUD or CUD was only moderate. However, the substantially simplified, proposed ICD-11 dependence criteria identified significantly more alcohol and cannabis dependence diagnoses compared to DSM-5 M/S, and DSM-IV and ICD-10 dependence. Despite the differences in prevalence for proposed ICD-11 dependence and DSM-5 M/S, concordance of these diagnoses was relatively high (0.73 to 0.78). The higher prevalence of proposed ICD-11 dependence results from its lower threshold (2 of 3 dependence criteria) and the relatively common report of Tolerance and Much Time spent using in this adolescent treatment sample. Switching of diagnostic status between proposed ICD-11 dependence and DSM-5 M/S was due to type of symptom endorsed, rather than total number of symptoms reported, highlighting ongoing issues in the conceptualization of SUD and consistency of case identification across systems.
As found in other studies, in this adolescent treatment sample, prevalence of DSM-IV AUD/CUD was higher relative to ICD-10 (Hasin et al., 1996; Pollock et al., 2000) , and higher relative to proposed ICD-11 and DSM-5 (Lago et al., 2016) . However, in contrast to the current study, a pediatric sample found that SUD prevalence was higher in DSM-5 compared to DSM-IV (Kelly et al., 2014) . Differences across diagnostic systems in who meets criteria for an SUD have important implications for identifying youth in need of treatment, such that DSM-IV and DSM-5 appear to provide broader coverage (i.e., identifies more cases with an AUD or CUD) relative to the proposed ICD-11 SUD diagnostic algorithm.
In this adolescent treatment sample, the higher prevalence of DSM-IV AUD/CUD relative to proposed ICD-11 and A1 to A4 refers to the 4 DSM-IV substance abuse criteria. D1 to D7 refers to the 7 DSM-IV substance dependence criteria.
DSM-5 was due to the relatively frequent endorsement of DSM-IV abuse symptoms (e.g., Interpersonal Problems, Role Impairment) and the 1 symptom threshold to diagnose DSM-IV abuse. Although proposed ICD-11 harmful use also only requires 1 symptom, report of psychological or physical problems due to substance use was relatively rare in this adolescent treatment sample, resulting in the low prevalence of the harmful use diagnosis in this study, and as reported in other work . Differences in the relative prevalence of diagnoses across studies may be due to factors such as sample characteristics (e.g., adult general population, pediatric patients, treatment samples), differences in the diagnostic measure used, how broadly or narrowly symptoms are defined, and extent of probing used (Chung et al., 2002; Lane et al., 2016) . Importantly, there was greater similarity in the rank ordering of diagnostic prevalence among studies that sampled individuals with greater substance use severity (Hasin et al., 1996; Pollock et al., 2000) .
The most substantial change for proposed ICD-11 SUD involves the radical simplification of the algorithm to diagnose dependence. Proposed ICD-11's simplified criteria, which are intended to reduce clinician burden, might result in less information (e.g., relative to DSM-5) on specific criteria endorsed by an individual. Information on which symptoms were endorsed, however, can be relevant to treatment planning, monitoring treatment progress, and is also important for refining the diagnostic algorithm . Further, prior research indicates that specific criteria tend to indicate lower (e.g., tolerance) and higher (e.g., withdrawal) levels of SUD severity for substances such as alcohol, cannabis, and cocaine Hartman et al., 2008; Kopak et al., 2012; Langenbucher et al., 2004; Malone and Hoffmann, 2016; Martin et al., 2006) . In this regard, each ICD-11 dependence criterion represents a cluster of symptoms, of which the symptom with the lowest SUD severity will typically determine whether a dependence criterion is present, because the less severe symptom is generally reported more commonly than the more severe symptom. For example, ICD-11's physical dependence criterion consists of Tolerance and Withdrawal, and would typically be met by endorsing Tolerance, which is lower in severity than Withdrawal. Taking into account the typical level of SUD severity indicated by a symptom could help to refine the proposed ICD-11 dependence algorithm.
Adolescents who met criteria for proposed ICD-11 dependence typically reported symptoms of Tolerance and Much Time spent using, which generally represent the ability to consume a relatively high quantity per occasion (Tolerance) and indicate a relatively high frequency of use (Much Time). In comparison, impaired control over use, a core feature of dependence (Edwards and Gross, 1976) , was reported relatively infrequently in this adolescent treatment sample before treatment, although a minority of cases reported initial onset of efforts to quit or cut down in the context of being in treatment. Although no symptom is required for a diagnosis of dependence in the classification systems examined here, the absence of symptoms of impaired control over use could cast doubt on whether an individual shows a compulsive pattern of use consistent with dependence (Edwards and Gross, 1976) and could contribute to "overdiagnosis" of dependence and "false-positive" diagnoses of dependence. Alternatively, some individuals, particularly in early stages of dependence, might engage in a pattern of heavy substance use (i.e., high quantity consumed per occasion and high frequency of use), as indicated by symptoms such as Tolerance and Much Time, and report no attempt to control or limit use (Chung and Martin, 2005) . These individuals would be captured by proposed ICD-11 dependence, but likely would not be identified as having a dependence diagnosis by the other classification systems. Diagnosing dependence according to proposed ICD-11, based on a minimum of 2 symptoms, one of which is Tolerance, requires caution because Tolerance is a relatively mild symptom in adolescents (Chung et al., 2002; Gelhorn et al., 2008; Martin et al., 2006) , and as a possible indicator of typical level of consumption has demonstrated limited predictive validity as a dependence criterion (Chung et al., 2001 (Chung et al., , 2004b Langenbucher et al., 1997) . These caveats need to be taken into consideration when applying the proposed ICD-11 dependence algorithm to youth, to minimize the possibility of "false-positive" dependence diagnoses.
Prevalence of proposed ICD-11 dependence was also higher compared to DSM-5 M/S SUD, although concordance between the diagnoses was relatively high for both alcohol and cannabis (kappas = 0.73 and 0.78) in this adolescent sample. Concordance of these diagnoses was slightly higher in this treatment sample, compared to an Australian population sample (alcohol = 0.70; cannabis = 0.63) (Lago et al., 2016) , possibly reflecting greater SUD severity in a treatment sample. One type of diagnostic disagreement between proposed ICD-11 dependence and DSM-5 M/S SUD of particular note in this treatment sample involved the small number of youth who met criteria for DSM-5 M/S, but not proposed ICD-11 dependence. For this small group of youth in treatment, diagnostic disagreements occurred due to endorsement of DSM-IV abuse symptoms (e.g., Role Impairment, Interpersonal Problems, Hazardous Use) that are not used to diagnose proposed ICD-11 dependence. In this regard, there was greater heterogeneity in the types of symptoms reported by youth with DSM-5 M/S, and who did not have proposed ICD-11 dependence. For the larger number of cases that met criteria for proposed ICD-11 dependence, but did not have a DSM-5 M/S use disorder, disagreements occurred due to the relatively frequent report of certain symptoms (e.g., Tolerance, Much Time), and proposed ICD-11's lower threshold for a dependence diagnosis. Compared to DSM-5 M/S, proposed ICD-11 dependence not only diagnosed more individuals, but also identified a somewhat more homogenous group of individuals in terms of the type of symptoms reported. The extent to which the greater homogeneity of symptoms reported among those with proposed ICD-11 dependence has specific advantages in determining type of treatment to be provided warrants further study.
Study limitations need to be considered. Specifically, results may not be generalizable beyond adolescents admitted to outpatient substance use treatment, which may reflect biases in referral and receipt of treatment. In addition, use of a treatment sample may result in greater endorsement of certain symptoms (e.g., quit or cut down) due to the context of participating in treatment. Generalizability also is limited given that the majority of participants were male, Caucasian, and reported primary drug was alcohol and/or cannabis. Analyses were limited to AUDs and CUDs and did not examine other substances. The draft ICD-11 SUD criteria used here are being examined in secondary data analyses and field tested and are subject to revision (Poznyak, 2016) . The research interview used in this study did not include the proposed ICD-11 symptom "family harmed by substance use," and thus underestimates the prevalence of proposed ICD-11 harmful use diagnoses. Importantly, this omission would not affect results regarding greater prevalence of dependence in proposed ICD-11 compared to the other classification systems. This study's cross-sectional data did not address whether the proposed ICD-11 SUD criteria have greater concurrent or predictive validity than other classification systems, although prior research has addressed the reliability and validity of DSM-IV, DSM-5, and ICD-10 SUD diagnoses (Hasin et al., 2006 (Hasin et al., , 2013a Martin et al., 2008) . As diagnostic assessments were conducted as part of a research study, application of the simplified, proposed ICD-11 SUD algorithm in a treatment setting by clinicians was not tested.
This study of adolescents in addictions treatment found higher prevalence of proposed ICD-11 dependence compared to DSM-5 M/S SUD. Relative to DSM-5 M/S SUD, the simplified, proposed ICD-11 dependence algorithm identified a somewhat more homogeneous group in terms of the type of symptom reported. Proposed ICD-11 dependence also diagnosed significantly more cases compared to ICD-10 dependence, on which the ICD-11 draft dependence algorithm is based. ICD-11's proposed simplification of dependence criteria appears to "overidentify" cases of dependence and could potentially generate more "false-positive" diagnoses of dependence relative to other systems. Study findings highlight important inconsistencies in the coverage of cases across diagnostic systems that impact determination of treatment need. Issues remain regarding appropriate thresholds and type of symptoms to be used in determining SUD diagnosis, particularly when applied to youth. A1 to A4 refers to the 4 DSM-IV substance abuse criteria. D1 to D7 refers to the 7 DSM-IV substance dependence criteria.
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